
Acetylcysteine Powder, also known as NAC or N-acetyl-L-cysteine, is a water-soluble amino acid derivative used in capsules, tablets, sachets and protected powder blends. Bulk supply is supported by batch-specific specifications, quality documentation and application-focused technical review.
| Item | Specification / Supply Information |
|---|---|
| Product name | Acetylcysteine Powder |
| Chemical name / synonyms | N-acetyl-L-cysteine; N-acetylcysteine; NAC |
| CAS number | 616-91-1 |
| Molecular formula / weight | C₅H₉NO₃S; 163.19 g/mol |
| Ingredient category / source | Sulfur-containing amino acid derivative; non-botanical source confirmed by project |
| Processing | Purification, crystallization, drying, milling, screening and batch release |
| Grade | Food, supplement or project-specific grade, subject to batch qualification |
| Assay | Commonly 98.5–101.0% on a dry basis when specified; confirmed by batch |
| Appearance / sensory profile | White to off-white crystalline powder with a characteristic sulfur-like odor and acidic taste |
| Carrier | Typically carrier-free; project-specific premixes available |
| Particle size | Typically 60–80 mesh; alternative particle-size distributions subject to confirmation |
| Moisture / residue on ignition | Controlled against the approved specification; water activity is not routinely published |
| Bulk density / flowability | Evaluated when required for capsule filling, tablet compression or automated dosing |
| Solubility / solution behavior | Water-soluble; acidic in aqueous solution; finished-product performance depends on formulation |
| Main applications | Capsules, tablets, sachets, stick packs, powder blends and effervescent systems |
| Shelf life / storage | Typically 24 months when sealed and stored in a cool, dry environment |
| Origin | China manufacture available; country of origin confirmed by batch |
| Dietary / supporting declarations | Vegan, allergen, GMO, gluten and irradiation statements provided when supported |
| Documentation / certifications | COA, TDS, SDS and specification; certifications confirmed against applicable facility and batch records |
| Standard MOQ / lead time | Typically 25 kg; commonly 7–15 working days after project confirmation |
Final acceptance criteria, testing methods and optional parameters are confirmed against the approved batch specification.
Physical and chemical controls
| Parameter | Typical Control |
|---|---|
| Appearance | White to off-white crystalline powder |
| Identification | FTIR, HPLC retention time or another agreed identification method |
| Assay | Commonly 98.5–101.0% on a dry basis when specified |
| Related substances / oxidation indicators | Controlled against approved impurity and stability requirements |
| Specific optical rotation | Available for stereochemical review when required |
| Loss on drying | Meets approved batch limits |
| Residue on ignition | Meets approved batch limits |
| Particle size | Typically 60–80 mesh or an agreed particle-size distribution |
| Solution clarity / color / pH | Evaluated at an agreed concentration for relevant applications |
| Residual solvents | GC testing when process or market requirements apply |
| Iron / copper | Optional reporting for oxidation-sensitive formulations |
Heavy metals
| Parameter | Typical Control |
|---|---|
| Lead | Controlled against approved limits |
| Arsenic | Controlled against approved limits |
| Cadmium | Controlled against approved limits |
| Mercury | Controlled against approved limits |
Microbiology
| Parameter | Typical Limit |
|---|---|
| Total plate count | Commonly ≤1,000 CFU/g or according to the approved specification |
| Yeast and mold | Commonly ≤100 CFU/g or according to the approved specification |
| E. coli | Negative according to the agreed test amount |
| Salmonella | Negative according to the agreed test amount |
| Staphylococcus aureus | Negative when included in the approved specification |
Evaluating an NAC batch requires more than checking the reported assay. Confirm the analytical reporting basis, identity result, related-substances profile and loss-on-drying value against the approved specification. Specific optical rotation can support stereochemical review, while oxidation-related indicators help identify stability concerns relevant to storage or processing. Particle-size distribution and bulk density should be assessed together when capsule filling, tablet compression or automated sachet dosing requires consistent material behavior.
For beverage powders, clear liquids or other appearance-sensitive applications, review solution clarity, color and pH at an agreed concentration. Iron and copper reporting may be appropriate where mineral salts, metal-contact surfaces or oxidation-sensitive systems create additional formulation risk. Microbiological criteria and individual heavy-metal controls should match the intended application and applicable market requirements. Batch identification, retained samples and consistent technical documentation support supplier qualification, complaint investigation and repeat-order comparison. These checks are most useful when integrated into a documented raw material quality control process before commercial batch release.
| Application Format | Key Evaluation |
|---|---|
| Capsules | Fill weight, powder density, flowability and content uniformity |
| Tablets | Active loading, excipient compatibility, compression and friability |
| Sachets / stick packs | Serving weight, moisture protection, dissolution and flavor |
| Powder blends / beverage powders | Blend uniformity, acidity, dispersion and ingredient compatibility |
| Effervescent tablets / granules | Humidity control and interactions with acids, carbonates and flavors |
| Gummies / RTD beverages / clear liquids | Heat exposure, oxygen, sensory changes and storage stability |
Formulation considerations
Formulation development should assess NAC within the complete finished-product system. Capsule projects require reliable filling and consistent unit weights, while tablet production depends on excipient compatibility, compression behavior and content uniformity. In sachets and beverage powders, evaluate dissolution, acidity, flavor coverage and blend segregation under realistic serving and storage conditions. Effervescent formats require additional environmental controls to limit premature reactions during processing.
Gummies, ready-to-drink beverages and clear liquids need broader testing because heat exposure, dissolved oxygen, pH and moisture can influence appearance, odor and ingredient stability. Mineral-containing prototypes should be checked for color changes, sensory drift and relevant oxidation indicators. Add the ingredient late in processing where practical, minimize unnecessary aeration and select packaging suitable for the expected distribution environment. Confirm production readiness through representative pilot batches, stability assessment and agreed release criteria. Where dosage-format selection, compatibility studies or prototype refinement require coordinated development, custom formulation support can help align technical requirements with the intended application.
| Item | Supply Information |
|---|---|
| Sample / pilot packs | 100 g, 500 g and 1 kg evaluation samples; 1–5 kg pilot packs available |
| Bulk packaging | Typically 25 kg fiber drums or cartons |
| Inner protection | PE, double-PE or foil-laminate liners based on handling and moisture-control requirements |
| Storage conditions | Keep tightly sealed in a cool, dry location away from unnecessary heat, light and moisture. |
| Shelf life | Typically 24 months under approved sealed-storage conditions; confirm against batch labeling. |
| Batch labeling | Product name, batch number, net weight and applicable manufacturing, retest or expiry information |
| Logistics / export support | Courier, air or sea shipment with agreed packing, commercial and origin documentation |
| Item | Supply Information |
|---|---|
| Standard MOQ | Typically 25 kg for commercial bulk orders |
| Sample availability | 100 g, 500 g and 1 kg quantities for laboratory evaluation and supplier approval |
| Standard lead time | Commonly 7–15 working days after specification and packaging confirmation |
| Custom specifications | Additional time may be required for alternative particle size, tighter limits or supplementary testing. |
| Core documents | Batch COA, TDS, SDS and product specification |
| Declarations / certifications | Provided only when supported by applicable facility, product and batch records |
| Regulatory review | Confirm NAC suitability for the intended destination market, product category and labeling requirements. |
| Inquiry requirements | Provide application format, order quantity, target specification, document requirements and preferred delivery timeline. |
Request an Acetylcysteine Powder quote, sample and batch documents by sharing your application, quantity and specification requirements.
Share your target specification, application, quantity and document needs. We will help confirm suitable options, COA/TDS/SDS support and bulk supply details.
Explore related ingredients for formula comparison, complementary applications and alternative sourcing options across food, beverage, supplement and wellness projects.